Saurav Chemicals is an API manufacturer. It holds 2 active US drug master files across a filed portfolio of 6 molecules. Customs aggregates show $4.7M of exports covering 53 molecules to 22 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Atropine | SFDA (Saudi Arabia) | 1 |
| Celecoxib | US FDA | 1 |
| Chlorzoxazone | US FDA | 1 |
| Dexketoprofen | SFDA (Saudi Arabia) | 1 |
| Pregabalin | SFDA (Saudi Arabia) | 1 |
| Vildagliptin | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2025 | Not reported | $4.7M | 22 |
| 2024 | Not reported | $22.6M | 51 |
| 2023 | Not reported | $39.8M | 45 |
| 2022 | Not reported | $24.0M | 50 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Saurav Chemicals comes back tiered against every other supplier able to file there.
Start for free